Abstract:Background: Gap junctions, as one of the major ways to maintain social connections between cells, are now considered as one of the potential regulators of tumor metastasis. However, to date, studies on the relationship between gap junctions and colorectal cancer (CRC) are limited.Methods: We synthesized connexins-coding gene expression data from public Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. Bioinformatics analysis was performed using R software and several database resources such as MEXPRESS database, Gene Set Cancer Analysis (GSCA) database, Human Protein Atlas (HPA) database, Tumor Immune Single Cell Hub (TISCH) database, Search Tool for Retrieval of Gene Interaction Relationships (STRING), and Cytoscape software, etc., to investigate the biological mechanisms that may be involved in connexins. Immunofluorescence and immunohistochemical staining were used to validate the expression and localization of GJA4.Results: We found that CRC patients can be divided into two connexin clusters and that patients in cluster C1 had shorter survival than in cluster C2. The infiltration of M1 macrophages and NK cells was lower in cluster C1, while the levels of M2 macrophages and immune checkpoints were higher, indicating an immunosuppressed state in cluster C1. In addition, the epithelial-mesenchymal transition (EMT) phenotype was significantly activated in cluster C1. We observed that GJA4 was up-regulated in colorectal cancer tissues, which was related to poor prognosis. It was mainly expressed in fibroblasts, but the expression levels in normal intestinal epithelial cells were low. Finally, we found that GJA4 was associated with M2 macrophages and may be a potential immunosuppressive factor.Conclusion: We found that there is a significant correlation between abnormal connexins expression and patients' prognosis, and connexins play an important role in stromal-tumor interactions. Connexins, especially GJA4, can help enhance our understanding of tumor microenvironment (TME) and may guide more effective immunotherapeutic strategies.

Connexin: a new perspective of tumor therapy

Connexin 43 and Tumors

Connexin-43 in Cancer: Above and Beyond Gap Junctions!

Gap Junction Intercellular Communication and Cancer

Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications

An Analysis Regarding the Association Between Connexins and Colorectal Cancer (CRC) Tumor Microenvironment

Connexins in colorectal cancer pathogenesis

Connexins in Lung Cancer and Brain Metastasis

Endocytic trafficking of connexins in cancer pathogenesis

Roles of Connexin in Breast Cancer

Gap Junctions Mediate Glucose Transfer to Promote Colon Cancer Growth in Three-Dimensional Spheroid Culture.

Role of Connexins 30, 36, and 43 in Brain Tumors, Neurodegenerative Diseases, and Neuroprotection

The Advances in Chemokine Receptors CXCR1/2 and Cancer

Non-junctional Cx32 Mediates Anti-Apoptotic and Pro-Tumor Effects Via Epidermal Growth Factor Receptor in Human Cervical Cancer Cells

[In Situ Expression of Connexins in Various Carcinomas].

Impact of Connexin 43 Coupling on Survival and Migration of Multiple Myeloma Cells.

Connexin 43, a new therapeutic target for cardiovascular diseases

The Role of Cxc Chemokines and Their Receptors in the Progression and Treatment of Tumors

CXC Chemokine Receptors in the Tumor Microenvironment and an Update of Antagonist Development

Integrative analyses identified gap junction beta-2 as a prognostic biomarker and therapeutic target for breast cancer

Connexins: junctional and non-junctional modulators of proliferation